Cite
HARVARD Citation
Freeman, K. (2016) Clinical effectiveness and cost-effectiveness of use of therapeutic monitoring of tumour necrosis factor alpha (TNF-ά) inhibitors [LISA-TRACKER® enzyme-linked immunosorbent assay (ELISA) kits, TNF-ά-Blocker ELISA kits and Promonitor® ELISA kits] versus standard care in patients with Crohn’s disease : systematic reviews and economic modelling. [Online]. Southampton : NIHR Journals Library. Available from: http://access.bl.uk/ark:/81055/vdc_100038218805.0x000001